Patents, Policy & Guidelines

In the context of research impact evaluation, a key pathway to achieving real-world change is the translation of evidence into policy and clinical practice. Our group actively contributes to this process through involvement in the development of clinical guidelines, consensus statements, and policy documents. We bring together methodological expertise, clinical experience, and a global perspective, ensuring that our contributions are both rigorous and relevant.

We have played leadership roles in several national and international initiatives, and our research has been cited in recommendations issued by the World Health Organization, national health ministries, and leading medical societies. These efforts reflect our commitment to advancing science that informs practice and improves health outcomes worldwide.

📚 Our Research Cited in Patents, Policy Documents and Guidelines

Our scientific publications have been cited in several key documents, including (Under construction):

• 10 articles were cited in 12 Patents (source: Dimensions)
• 26 articles were cited in 29 Policy Documents (source: Dimensions)
• 15 articles were cited in 15 Guidelines (source: Dimensions)
• 04 articles were cited 14 Wikipedia entries (source: Dimensions)

🧭 Guidelines We’ve Authored or Contributed To

🗂️ Direct Contributions

📄 WHO, Expanding our understanding of Post COVID-19 condition (2021)

Member of the Working Group (WG1), Pathophysiology 📎 See Webnar

📄 ICM Practice Guidelines, Dexmedetomidine (2022)

Rapid Practice Guidelines from the European Society of Intensive Care Medicine (ESICM) 📎 View guideline (PDF)

📄 Consensus, Global Climate and Health Summit 2025 (2025)

Guiding Principles Consensus Statement, Physiological Society 📎 Read on PhySoc

📄 Conference Reports and Expert Panel, Resuscitation fluids (2025)

European Society of Intensive Care Medicine (ESICM) 2025 clinical practice guideline on fluid therapy in adult critically ill patients 📎 View guideline (PDF)